President Biden's executive order to increase access to contraception
In the USA, President Joe Biden will be signing an executive order to expand access to contraception.
The order comes after concerns have been raised about the security of access to contraception since bans on abortion have come into play and the Supreme Court ruling overturning Roe v Wade in 2022.
The aim of the order is to increase avenues for women to gain access to contraception, and to decrease costs associated, as reproductive rights advocates have been campaigning highlighting the barriers women are facing in acquiring contraception, leaving millions of women vulnerable and without contraception.
The ruling could help to encourage private health insurance agents to offer broader coverage and contraception options, such as covering multiple products and increasing efficiency in the process of obtaining appropriate care, all coming under the Affordable Care Act.
The order will also mean increased access to over the counter contraception, increase coverage of contraception through Medicare, promote family planning services through Medicaid, support access to contraception to vulnerable groups and students, and to further research and data collection on contraception access across the USA.
"This action will build on the progress already made under the Affordable Care Act by further reducing barriers that women face in accessing contraception prescribed by their provider," a White House fact sheet on the order proclaimed.
“Today’s announcements build on actions that the Biden-Harris Administration has already taken to protect access to contraception, including in response to two prior Executive Orders directing actions to safeguard access to reproductive health care services” stated the fact sheet.
In 2022, the US House of Representatives, which was largely controlled by the Democratic party at the time, passed a bill to request a law with the aim of protecting women’s access to contraception. However, on consideration by the Senate, the bill was eventually blocked from passing into law by Republican representatives.
As recently as last week, two Senators moved to introduce a new bill to achieve better protection for access to contraception, for this bill to get passed, it will need to be signed off by Democratic-controlled Senate and the Republican-controlled House.
Related News
-
News Women in Pharma: Marketing for the other half in healthcare
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. This instalment highlights not only the importance of ma... -
News Gilead shows support for equitable healthcare for indigenous populations
Pharmaceutical companies are starting to acknowledge their responsibility to making access to medicine equitable to all, and Gilead Sciences are working towards their biggest commitment in this aspect, via a new initiative to enable health equity for A... -
News Women in Pharma: Advancing gender diversity & healthcare equality
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Women in Pharma: Gearing up for systemic change
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Allyship in Pharma – Building Industry Inclusivity
Provision of healthcare is an important aspect of people's lives, especially those in the LGBTQIA+ community. Pharmaceutical companies are working to improve this access to medicine and representation for the population. -
News CPHI Podcast Series: Celebrating International Women’s Day by championing women’s health
The March episode of the CPHI Podcast Series is dedicated to celebrating International Women's Day, followng the theme #EmbraceEquity in the context of women's health. -
News Women in Pharma – Karin von Kienlin Pharmapack 2023
This year at Pharmapack 2023 in Paris, France, the CPHI Online team interviewed several leading women in the pharmaceutical industry about what it means to be a woman working in this field. -
News Women in Pharma – Asmita Khanolkar Pharmapack 2023
At Pharmapack 2023, the CPHI team interviewed several leading women in the pharmaceutical industry about what it means to be a woman working in this field. Ahead of International Women’s Day on March 8, 2023, we are proud to provide a p...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance